KKR Takes Brar as Senior Advisor

Private equity firm KKR will appoint DS Brar as a senior advisor. Brar will join the firm in Mumbai, where he will work with KKR on current and prospective investments with the firm. Brar serves on the Boards of MphasiS Limited – a subsidiary of Hewlett Packard, Maruti Suzuki India Limited and Moksha8. He is also Special Advisor to the Board of Directors of Adamas Pharmaceuticals Inc. and a Consultant to Teva Pharmaceuticals.

PRESS RELEASE:

KKR Appoints DS Brar as Senior Advisor
MUMBAI, India & NEW YORK– Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, “KKR”) today announced the appointment of DS Brar as a Senior Advisor to the firm.
“I am honored to have the opportunity to work with KKR in bringing value to both Indian and global companies across a broad range of offerings.”
Sanjay Nayar, a Member of KKR and head of the firm’s India operations, said, “DS Brar is one of the most respected business managers in India. He has a breadth of business, economic and government experience, and we are very pleased he will bring his expertise to bear on our current and prospective investments as a Senior Advisor to the firm.”
Mr. Brar currently holds Board positions in various Indian and international companies. From 2000 to 2007, Mr. Brar served as a Director of Reserve Bank of India (RBI) and was also a Member of the Inspection and Audit Sub-Committee of the Central Board of Directors of the RBI. In his new role for KKR, Mr. Brar will also serve on the firm’s Asia portfolio management committee, which interacts with company management, monitors all of KKR’s private equity investments in the region, and provides guidance and input on the operations of the companies.
“KKR is a premier global investment firm with an outstanding leadership team,” said Mr. Brar. “I am honored to have the opportunity to work with KKR in bringing value to both Indian and global companies across a broad range of offerings.”
Mr. Brar spent the major part of his career with Ranbaxy Laboratories Limited, India’s largest pharmaceutical company, and was named its CEO & Managing Director in 1999. In 2004, Mr. Brar started his entrepreneurial journey and ventured into GVK Biosciences, a leading contract research organization providing discovery & development services to global life sciences companies.
Mr. Brar serves on the Boards of MphasiS Limited – a subsidiary of Hewlett Packard, Maruti Suzuki India Limited and Moksha8. He is also Special Advisor to the Board of Directors of Adamas Pharmaceuticals Inc. and a Consultant to Teva Pharmaceuticals. Mr. Brar is also a Member of the Board of Governors of Indian Institute of Management, Lucknow (IIML).
As a member of the National Council of the Confederation of Indian Industry (CII) Mr. Brar was Chairman of CII’s Indian MNC Council. He has served as a member of the Executive Committee of Federation of Indian Chambers of Commerce and Industry (FICCI). Mr. Brar was a Member of Prime Minister’s Task Force on pharmaceuticals and knowledge-based industries which drafted the blue print for the growth and global expansion of the Indian pharmaceutical industry.
Mr. Brar graduated with a Bachelor of Engineering (Electrical) degree from Thapar Institute of Engineering & Technology, Patiala. He further completed his Masters Degree in Business Administration with top rank (Gold Medal) from the Faculty of Management Studies, University of Delhi. Mr. Brar was honored with the Dean’s Medal from the Tufts University School of Medicine in 2004. The Federation of Asian Biotech Associations (FABA) conferred on Mr. Brar the “FABA Special Award 2011” for his contribution to the biopharma sector.
KKR’s Senior Advisors are part of the firm’s integrated model of value creation. They include current and former senior executives who bring unique leadership skills to complement the work of KKR investment professionals and the operational executives at KKR Capstone, and serve as liaisons to manage relationships with current and future investment partners.
About KKR
Founded in 1976 and led by Henry Kravis and George Roberts, KKR is a leading global investment firm with $61.9 billion in assets under management as of June 30, 2011. With offices around the world, KKR manages assets through a variety of investment funds and accounts covering multiple asset classes. KKR seeks to create value by bringing operational expertise to its portfolio companies and through active oversight and monitoring of its investments. KKR complements its investment expertise and strengthens interactions with investors through its client relationships and capital markets platform. KKR is publicly traded on the New York Stock Exchange (NYSE: KKR). For additional information, please visit KKR’s website atwww.kkr.com.